Detalhe da pesquisa
1.
CALR mutation burden in essential thrombocythemia and disease outcome.
Blood
; 143(13): 1310-1314, 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38252902
2.
Autoimmune myelofibrosis: A Mayo Clinic series of 22 patients.
Br J Haematol
; 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38698680
3.
Venetoclax plus hypomethylating agents in DDX41-mutated acute myeloid leukaemia and myelodysplastic syndrome: Mayo Clinic series on 12 patients.
Br J Haematol
; 204(1): 171-176, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37710381
4.
TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q).
Br J Haematol
; 204(4): 1243-1248, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38083865
5.
Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents.
Br J Haematol
; 204(4): 1232-1237, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38311378
6.
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
Blood
; 140(11): 1200-1228, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35767897
7.
Prognostic relevance of clonal hematopoiesis in myeloid neoplastic transformation in patients with follicular lymphoma treated with radioimmunotherapy.
Haematologica
; 109(2): 509-520, 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646653
8.
Cladribine plus cytarabine plus venetoclax in acute myeloid leukemia relapsed or refractory to venetoclax plus hypomethylating agent.
Haematologica
; 2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38546692
9.
Prognostic impact of SF3B1 mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases.
Haematologica
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38450522
10.
Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms.
Haematologica
; 2024 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299584
11.
New drugs in myelofibrosis: Critical assessment of additional value to monotherapy with JAK inhibitors.
Am J Hematol
; 99(5): 978-981, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38332640
12.
Venetoclax in the treatment of acute myeloid leukemia: Beyond VIALE-A.
Am J Hematol
; 99(4): 515-518, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38375926
13.
Momelotinib expands the therapeutic armamentarium for myelofibrosis: Impact on hierarchy of treatment choices.
Am J Hematol
; 99(2): 300-308, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38164985
14.
Incidental discovery of KIT-mutated mastocytoma in a colon polyp.
Am J Hematol
; 99(5): 973-974, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38270251
15.
Granularity in disease classification impacts survival prediction in advanced systemic mastocytosis: A single institution study of 329 informative cases.
Am J Hematol
; 99(1): 21-27, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37772442
16.
Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.
Am J Hematol
; 99(1): E1-E4, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37688525
17.
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients.
Am J Hematol
; 99(2): 193-202, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38071734
18.
Venetoclax duration (14 vs. 21 vs. 28 days) in combination with hypomethylating agent in newly diagnosed acute myeloid leukemia: Comparative analysis of response, toxicity, and survival.
Am J Hematol
; 99(2): E63-E66, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38100217
19.
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.
Br J Haematol
; 202(2): 279-283, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37144345
20.
Momelotinib (JAK1/JAK2/ACVR1 inhibitor): mechanism of action, clinical trial reports, and therapeutic prospects beyond myelofibrosis.
Haematologica
; 108(11): 2919-2932, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861402